Drug- or toxin-induced pulmonary arterial hypertension

MONDO:0017149

Drug- or toxin-induced pulmonary arterial hypertension (PAH) is a form of pulmonary arterial hypertension (PAH) secondary to the exposition to drugs. Drug- or toxin-induced PAH is characterized by elevated pulmonary arterial resistance leading to right heart failure. Drug or toxin induced PAH is progressive and potentially fatal.

Also known as: drug- or toxin-induced PAH

26 clinical trials for this condition and its sub-types, 4 tagged with Drug- or toxin-induced pulmonary arterial hypertension itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Pulmonary arterial hypertension (208)

Including sub-types (26) Tagged with Drug- or toxin-induced pulmonary arterial hypertension (4)

Trials to join now! 15 Not yet recruiting 6 Not yet finished but already full! 1 Completed 4

Massive study aims to redefine Lung-Heart disease

Knowledge-focused Ongoing

This study looks at nearly 1,200 people with or at risk for pulmonary hypertension (high blood pressure in the lungs). Researchers use many advanced tests to find new ways to classify the disease and identify biomarkers. The goal is to better understand the disease and improve fu…

Sponsor: The Cleveland Clinic • Aim: Knowledge-focused

Last updated Sep 11, 2026 00:00 UTC

Drug- or toxin-induced pulmonary arterial hypertension

Where it sits in the disease tree

Massive study aims to redefine Lung-Heart disease